Feline Herpesvirus (FHV‑1) — Management Guide for Owners and Clinicians

Comprehensive guide on FHV‑1: cause, diagnosis, ocular complications, antivirals (famciclovir), L‑lysine evidence, chronic carrier management and daily care.

Quick Overview

• What it is: Feline herpesvirus‑1 (FHV‑1) is an alpha‑herpesvirus that commonly causes upper respiratory disease and ocular disease (conjunctivitis, corneal ulcers, keratitis) in cats. After primary infection the virus establishes lifelong latency (typically in the trigeminal ganglia) and can reactivate.
• Who's at risk: Kittens, young cats, immunosuppressed cats, and cats in multicat environments (shelters, catteries) are most likely to show disease. Many adult cats are latently infected and intermittently shed virus, often without obvious signs.
• Prognosis: Most cats recover from acute infections with supportive care. Ocular disease can become chronic and may cause vision‑limiting conditions (e.g., corneal sequestrum). With appropriate management, quality of life is usually good, but some cats will have recurrent episodes requiring long‑term strategies.

Pathophysiology (explained simply)

FHV‑1 enters through the nose, mouth or eyes, replicates in mucosal and conjunctival epithelium, and causes inflammation and epithelial cell damage. The virus travels along sensory nerves to sensory ganglia (primarily the trigeminal ganglia) where it becomes latent. During latency the virus is quiescent but can reactivate with stress, steroid use, intercurrent illness or other immune suppression and travel back to the mucosa to cause clinical signs and viral shedding.

Breed‑specific risk factors and prevalence

• Prevalence: Serologic evidence of prior exposure is common in domestic cat populations worldwide; in some multicat populations >50–80% of adult cats have been exposed.
• Risk groups: Kittens and young cats, shelter/cattery populations, and immunocompromised cats are at highest risk for clinically significant disease.
• Breed considerations: No breed is uniquely susceptible to initial infection, but brachycephalic breeds (Persian, Exotic shorthair) and cats with conformational ocular surface disease may have more persistent ocular irritation and secondary problems. Indoor/outdoor lifestyle and multicat housing are stronger risk determinants than breed alone.

• Signs appear 2–6 days after exposure: sneezing, nasal discharge, conjunctivitis, chemosis, fever, lethargy, anorexia. Ocular signs often include conjunctival redness, mucopurulent discharge and blepharospasm.
• Ophthalmic lesions: dendritic corneal ulcers (superficial, branching), punctate erosions, stromal keratitis.

• Virus hides in trigeminal ganglia with no outward signs. Serology is usually positive; PCR from mucosa may be negative when latent.

• Triggered by stress, corticosteroids, illness, surgery, pregnancy, or other immune suppression. Clinical signs are often milder but may include ocular flare‑ups and corneal disease.

• Dendritic corneal ulcers: branching epithelial defects visible with fluorescein staining and slit lamp/ophthalmic exam. These are classic for FHV‑1.
• Stromal keratitis: deeper stromal inflammation can lead to scarring and vision impairment.
• Corneal sequestrum: a brown‑black focal plaque of necrotic cornea that often develops months after chronic herpetic keratitis. It is painful and frequently requires surgery.
• Chronic conjunctivitis and epiphora (tear overflow) are common in chronic carriers.

• Clinical exam: complete physical and ophthalmic exam (direct and slit‑lamp if available), fluorescein staining to identify corneal ulcers, tear production testing (Schirmer tear test), and intraocular pressure when indicated.
• Cytology: conjunctival or corneal cytology for secondary bacterial or fungal infection when appropriate.
• PCR: conjunctival or oropharyngeal swab PCR is the most sensitive and rapid test for detecting active viral shedding. Negative PCR does not exclude latent infection.
• Virus isolation: rarely done in routine practice; more for research or reference labs.
• Serology: not useful to diagnose active infection because many healthy cats are seropositive.
• Referral: refer to a veterinary ophthalmologist for persistent, recurrent or visually significant corneal disease (dendritic ulcers, stromal keratitis, corneal sequestrum) or if surgery is being considered.

Goals: reduce viral replication (if active), control secondary bacterial infection, control pain and inflammation (carefully), promote corneal healing, and prevent/minimize recurrence.

Supportive care

• Hydration, nutritional support (appetite stimulants if necessary), environmental humidification and cleaning of obstructed nares/conjunctiva.

• Trifluridine 1% ophthalmic solution: effective topical antiviral; typically used q4–6h (can be more frequent in severe infections). It can cause ocular irritation with frequent dosing and is expensive.
• Cidofovir 0.5% ophthalmic solution: used twice daily (BID) because of long intracellular half‑life; well tolerated and effective for FHV‑1 keratitis.
• Idoxuridine or vidarabine: older options; effective but often more irritating and less convenient.

• Famciclovir (oral): the prodrug of penciclovir; commonly used because of good activity against FHV‑1 in cats and generally good tolerability. Famciclovir is indicated for moderate to severe systemic or ocular disease and for some recurrent cases.

Antibacterial therapy (secondary infection)

• Topical broad‑spectrum antibiotic drops/ointments (e.g., tobramycin, ciprofloxacin ophthalmic, erythromycin ointment) are used to prevent/treat secondary bacterial infection when corneal ulcers or purulent conjunctivitis are present.
• Systemic antibiotics (e.g., doxycycline 5 mg/kg PO q12–24h) are used for more severe secondary infections or if systemic illness or sinusitis is present.

• Systemic NSAIDs/analgesics (as directed by your vet) and topical atropine for painful corneal disease may be used. Topical corticosteroids are CONTRAINDICATED in the presence of active corneal ulcers (they can worsen infection and slow healing) and only used under strict ophthalmologist guidance for certain immune‑mediated conditions.

• Corneal sequestra often require surgical removal (keratectomy) with or without conjunctival grafting. Surgery usually cures the sequestrum and relieves pain; post‑op medical management may include topical antivirals and antibiotics. Consultation with a veterinary ophthalmologist is recommended; success rates for vision and comfort after surgery are generally good though some recurrence is possible.

• Recombinant feline interferon omega (topical or systemic) has been used in some regions with variable results.
• L‑lysine: common supplement historically used to reduce FHV‑1 replication by competing with arginine. Evidence summary below.

• History: L‑lysine supplements (oral powder/tablets or lysine‑fortified food) were widely adopted to try to decrease FHV‑1 recurrences.
• Evidence: high‑quality clinical trials and systematic reviews have not shown consistent benefit for prevention or treatment of FHV‑1 clinical signs. Several studies suggest no reduction in clinical signs or virus shedding; some evidence even indicates possible adverse effects (changes in amino acid balance that could theoretically increase shedding). Major veterinary reviews recommend against routine use of L‑lysine for FHV‑1 prevention and advise discussing any use with your veterinarian.
• Bottom line: L‑lysine is not supported by robust evidence and is not a substitute for proven treatments like antivirals and good supportive care.

• Minimize stressors: stress is the most consistent trigger for reactivation. Reduce changes in routine, maintain stable social groupings, provide enriched environments and manage other illnesses promptly.
• Vaccination: core FHV‑1 vaccines (modified live or killed) do not prevent infection or latency but significantly reduce severity and duration of clinical disease and viral shedding; keep vaccinations up to date per your vet’s recommendations.
• Environmental control: good hygiene in multicat settings, isolation of acutely ill cats, and regular cleaning. FHV‑1, an enveloped virus, is readily inactivated by common disinfectants (dilute bleach solutions, quaternary ammonium disinfectants labeled for enveloped viruses) and by heat.
• Prophylactic antivirals: some clinicians use short courses of famciclovir around stressful events (boarding, shows, heat stress, anesthesia) for cats with frequent recurrences — only under veterinary guidance.
• Dental and general health: chronic pain or oral disease may contribute to stress and reactivation; address dental disease and systemic health issues.

• Schedule periodic checkups and eye exams for cats with history of ocular FHV‑1.
• Owners should monitor for early signs (eye redness, discharge, sneezing, reduced appetite) and start veterinary contact early — early treatment shortens episodes and reduces complications.
• For corneal disease, follow ophthalmologist recommendations for rechecks until complete healing and for monitoring grafts after surgery.

• Most cats recover from acute FHV‑1 infections with supportive care and experience a good quality of life.
• Some cats become chronic carriers with intermittent ocular flare‑ups; many live comfortably with episodic treatment and environmental management.
• Ocular complications (stromal scarring, sequestra) can cause permanent vision loss in affected eyes; surgical treatment of sequestra is often successful at restoring comfort and preserving vision.

• Keep your cat’s environment low stress: consistent routines, safe hiding places, pheromone diffusers (e.g., Feliway) may help.
• Monitor eyes daily: note any redness, discharge, blinks or squinting.
• Maintain vaccinations and parasite control as recommended.
• Hand hygiene and routine cleaning of bedding/litter boxes help reduce spread in multicat households; isolate symptomatic cats from kittens.
• Have a plan with your veterinarian for at‑home care and when to start antivirals if your cat is a known recurrent shedder.

Seek immediate veterinary care if you notice any of the following:

• Sudden severe squinting, pawing at the eye, or signs of severe ocular pain
• Corneal clouding, large corneal ulcer, or suspected corneal perforation (sudden collapse of the eye surface)
• Marked appetite loss, fever, severe lethargy, dehydration
• A kitten, pregnant cat, or immunosuppressed cat with acute respiratory or ocular signs

• FHV‑1 is a common cause of upper respiratory and ocular disease in cats; infection becomes latent and may recur with stress.
• Ocular complications range from self‑limiting conjunctivitis to sight‑threatening corneal disease and sequestrum; early ophthalmic care reduces complications.
• Famciclovir is the most widely used oral antiviral for clinical FHV‑1 in cats (dosing varies; consult your vet). Topical antivirals (cidofovir, trifluridine) are effective for corneal involvement.
• Routine L‑lysine supplementation is not supported by consistent evidence and is not recommended as a reliable prevention strategy.
• Long‑term management focuses on stress reduction, vaccination, early treatment of flare‑ups and surgical correction of advanced corneal disease when needed.

References and further reading

• Merck Veterinary Manual: Feline Herpesvirus 1 (FHV‑1). https://www.merckvetmanual.com/respiratory-system/viral-respiratory-diseases/feline-herpesvirus-1
• Maggs DJ. Feline herpesvirus 1 (FHV‑1) and feline ocular disease: An update. Vet Ophthalmol. (review articles and clinical reviews by Maggs and colleagues are widely cited for FHV‑1 ocular disease)
• AAFP and ISFM feline vaccination guidelines (discuss vaccine role in reducing severity). https://catvets.com/guidelines
• Plumb's Veterinary Drug Handbook (dosing references and drug safety notes)

Frequently Asked Questions